Management of Post-MI Patient with Residual Ischemia and Reduced LVEF

Immediate Priority: Invasive Evaluation

Coronary angiography is indicated in patients with documented ischemia on stress testing and heart failure symptoms or reduced LVEF to determine if revascularization can improve outcomes, according to the American College of Cardiology 1
The presence of a moderate-severity reversible defect indicates viable myocardium at risk that could benefit from revascularization (PCI or CABG depending on anatomy), as recommended by the American Heart Association 1

Beta-blockers are Class I recommendations for all patients with prior MI and LVEF <50%, with evidence-based options including carvedilol, metoprolol succinate, or bisoprolol, according to the American College of Cardiology 3, 1
The American Heart Association recommends starting with low-dose metoprolol succinate (25 mg daily) or carvedilol (3.125 mg twice daily) and titrate upward to target doses unless symptomatic bradycardia or hypotension develops 3
The European Society of Cardiology suggests that while valsartan 160 mg daily is appropriate as an ARB for post-MI patients with reduced LVEF, consider whether the dose is optimized 2, 3
Aldosterone antagonists are recommended in post-MI patients with LVEF <40% who are receiving therapeutic doses of ACE inhibitor/ARB and beta-blocker, according to the American College of Cardiology 2, 4
The American Heart Association recommends increasing atorvastatin from 40 mg to 80 mg daily for high-intensity statin therapy in all post-MI patients unless contraindicated 2, 5, 6
High-intensity statin therapy (atorvastatin 80 mg) should be initiated or continued in all post-MI patients unless contraindicated, with a target LDL-C <70 mg/dL (<1.8 mmol/L) or at least 50% reduction from baseline, as recommended by the European Society of Cardiology 2, 6

If significant stenosis in the LAD territory (supplying the apex), PCI is reasonable for single-vessel disease with moderate ischemia, according to the American College of Cardiology 1
If no significant obstructive disease, continue optimized medical therapy as outlined above, as recommended by the American Heart Association 7

Enroll in supervised cardiac rehabilitation program immediately, which improves functional capacity, reduces mortality, and is particularly important given excellent exercise tolerance, according to the American College of Cardiology 4, 1
Reassess LVEF in 40 days post-optimization of medical therapy and 3 months post-revascularization (if performed), and consider ICD if LVEF remains ≤35% despite optimal medical therapy, as recommended by the American Heart Association 3, 1
Target blood pressure <130/80 mmHg in this patient with CAD and prior MI, and avoid excessive diastolic BP lowering (<60 mmHg) which may worsen myocardial ischemia, according to the American College of Cardiology 1